Evidence map›Paper›PMID 32269628›Full record

ArticleOncology letters2020

Phosphorylated STAT3 expression linked to

Hirokazu Fukui, Jiro Watari, Xinxing Zhang, Ying Ran, Toshihiko Tomita, Tadayuki Oshima, Seiichi Hirota, Hiroto Miwa

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Leukaemia inhibitory factor in gastric cancer: friend or foe?Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hirokazu FukuiDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Jiro WatariDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Xinxing ZhangDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Ying RanDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Toshihiko TomitaDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Tadayuki OshimaDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Seiichi HirotaDepartment of Surgical Pathology, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Hiroto MiwaDivision of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine Hospital, Nishinomiya, Hyogo 663-8501, Japan.
Hyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancers (GCs) may develop in the gastric mucosa after elimination of

Indexed as

eradicationgastric cancermethylationproliferationSOCS3STAT3

Identifiers

PMID32269628
PMCPMC7115067
OpenAlexW3010805431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.